Roche Corleen M.
SEC insider (Form 3/4/5 filer). CIK 0001857905. Chief Financial Officer at IOVANCE BIOTHERAPEUTICS, INC. (IOVA) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in SAN CARLOS, CA.
Companies Roche Corleen M. has filed insider reports for
- IOVANCE BIOTHERAPEUTICS, INC. (IOVA): Officer, Chief Financial Officer
- CG Oncology, Inc. (CGON): Officer, CFO
Roche Corleen M.
CIK: 0001857905
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 6, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
ExerciseDirect50K shares- - Aug 6, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Tax PaymentDirect21.2K shares at avg. $6.21$132K - Mar 9, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectRestricted Stock Units
132.2K shares- - Aug 6, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectRestricted Stock Units
150K shares- - Aug 6, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
300K shares- - Apr 15, 2025CGON
CG Oncology, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
143.9K shares- - Oct 4, 2024CGON
CG Oncology, Inc.
AwardDirectStock Option (Right to Buy)
93.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 |  IOVA IOVANCE BIOTHERAPEUTICS, INC. | Exercise | 49,995 | - | $0 | Direct |
| Aug 6, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Tax Payment | 21,238 | $6.21 | $131,888 | Direct |
| Mar 9, 2026 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Restricted Stock Units | 132,200 | - | - | Direct |
| Aug 6, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Restricted Stock Units | 150,000 | - | - | Direct |
| Aug 6, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award Stock Option (right to buy) | 300,000 | - | - | Direct |
| Apr 15, 2025 |  CGON CG Oncology, Inc. | Award Employee Stock Option (Right to Buy) | 143,907 | - | - | Direct |
| Oct 4, 2024 | CGON CG Oncology, Inc. | Award Stock Option (Right to Buy) | 93,600 | - | - | Direct |
1-7 of 7 transactions